View More Recent Stories

Jan 2, 2025 12:51PM Biopharma 2025 Preview: 'Piper Sandler Sees Lots of Upside Opportunity'
Dec 16, 2024 08:03AM Crinetics Pharmaceuticals (CRNX) Appoints Isabel Kalofonos as Chief Commercial Officer
Dec 9, 2024 08:14AM Crinetics Pharmaceuticals (CRNX) Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients with Acromegaly
Nov 13, 2024 06:52AM Crinetics (CRNX) PT Raised to $81 at H.C. Wainwright
Oct 14, 2024 07:27AM Piper Sandler Reiterates Overweight Rating on Crinetics (CRNX)
Oct 9, 2024 06:05AM Crinetics Pharmaceuticals (CRNX) Prices Upsized 10M Share Offering at $50/sh
Oct 8, 2024 04:41PM After-hours movers: Astera Labs, Saratoga Investment, Kezar Life Sciences, and more
Oct 8, 2024 04:02PM Crinetics Pharmaceuticals (CRNX) Announces Proposed Public Offering of Common Stock
Sep 27, 2024 08:42AM Piper Sandler Reiterates Overweight Rating on Crinetics (CRNX)
Sep 26, 2024 04:06PM Crinetics Pharmaceuticals (CRNX) Submits New Drug Application for Paltusotine for the Treatment of Acromegaly
Sep 7, 2024 08:00PM Here's the list of biotech stocks that have key data catalysts in 2025
Aug 8, 2024 05:20PM Crinetics Pharmaceuticals (CRNX) Misses Q2 EPS by 8c
Jul 17, 2024 07:54AM Piper Sandler Reiterates Overweight Rating on Crinetics (CRNX)
Jul 2, 2024 07:59AM Piper Sandler Reiterates Overweight Rating on Crinetics (CRNX)
Jul 1, 2024 03:44PM Crinetics Pharmaceuticals (CRNX) +2200 September 50 calls trade at 50c
Jul 1, 2024 03:11PM Oppenheimer Reiterates Outperform Rating on Crinetics (CRNX)
Jun 21, 2024 04:48PM Crinetics Pharmaceuticals (CRNX) Files Mixed Shelf
View More Recent Stories